BRAF and melanoma: This Pik3cb mutant had little-to-no impact upon disease trajectory, with naevus onset and melanoma initiation similar to BRAF PTEN controls, although Pik3cb mutation did seem to result in improved overall survival (Supplementary Fig. S8E).